An open label study to evaluate the safety, and effect on treatment response, of MabThera in combination with methotrexate in patients with active rheumatoid arthritis who have had an inadequate response or intolerance to one or more anti-TNF agents.

Trial Profile

An open label study to evaluate the safety, and effect on treatment response, of MabThera in combination with methotrexate in patients with active rheumatoid arthritis who have had an inadequate response or intolerance to one or more anti-TNF agents.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2014

At a glance

  • Drugs Rituximab (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 May 2012 Actual end date Apr 2010 added as reported by ClinicalTrials.gov.
    • 18 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top